ICD-11 classes
16 Diseases of the genitourinary system
Diseases of the male genital system
Neoplasms of the male genital organs
Malignant neoplasms of male genital organs
2C82 — Malignant neoplasms of prostate
2C82.0 — Adenocarcinoma of prostate
ICD-11 2C82.0 — Adenocarcinoma of prostate
An adenocarcinoma arising from the prostate gland. It is one of the most common malignant tumours afflicting men. The majority of adenocarcinomas arise in the peripheral zone and a minority occurs in the central or the transitional zone of the prostate gland. Grading of prostatic adenocarcinoma predicts disease progression and correlates with survival. Several grading systems have been proposed, of which the Gleason system is the most commonly used. Gleason sums of 2 to 4 represent well-differentiated disease, 5 to 7 moderately differentiated disease and 8 to 10 poorly differentiated disease. Prostatic-specific antigen (PSA) serum test is widely used as a screening test for the early detection of prostatic adenocarcinoma.
The diagnosis includes nothing.
The diagnosis excludes nothing.
It has no clarifying diagnoses.
The diagnosis is coded elsewhere: